Recently, it was reported that CEMIP (cell migration-inducing and hyaluronan-binding protein) was associated with migration, invasion and drug resistance in various tumors [8–14], particularly in colon cancer, breast cancer, stomach cancer. This evidence concerns the gene CEMIP and breast carcinoma.